ngµç×ÓÓÎÏ·ÐÂÎÅÍøѶ£¨Í¨Ñ¶Ô±²Ü骣©ÈËÐÄÔ಻¾ßÓгÉÌå¸Éϸ°ûÒѳÉΪѧÊõ½ç¹²Ê¶¡£¡£¡£ÅßÌ¥·¢ÓýÖзºÆðµÄÐÄѪ¹Ü×æϸ°û£¨cardiovascular progenitor cells, CPCs£©ÊÇÌåÄÚΨһ¹«ÈϵľßÓÐÐļ¡·Ö»¯ÄÜÁ¦µÄ¸Éϸ°û£¬£¬£¬²¢¾ß±¸Ñª¹Üƽ»¬¼¡Ï¸°ûºÍѪ¹ÜÄÚƤϸ°û·Ö»¯Ç±ÄÜ£¬£¬£¬¾ßÓÐÁÉÀ«µÄÐÄÔàÔÙÉúÓ¦ÓÃÔ¶¾°¡£¡£¡£ÔÚÒÆÖ²ÖÁ¹£ËÀÐÄÔàºó£¬£¬£¬CPCs²»µ«¿ÉÔö²¹ÊÜËðµÄÐļ¡Ï¸°û£¬£¬£¬»¹¿ÉÒÔ̫ͨ¹ý»¯ÎªÃ«Ï¸Ñª¹Ü¸ÄÉƹ£ËÀÇøѪҺѻ·£¬£¬£¬Ôö½øÄÚÔ´ºÍÍâÔ´Ðļ¡Ï¸°û´æ»î¡£¡£¡£¶àÏîÑо¿Ö¤Êµ£¬£¬£¬ÒÆÖ²CPCs¿ÉÒÔÏÔ×ÅÌáÉýÐĹ£ºóÐĹ¦Ð§£¬£¬£¬²¢Õ¹ÏÖ³ö±È´¿´âÐļ¡Ï¸°ûÒÆÖ²¸üÏÔÖø³¤ÆÚµÄЧ¹û¡£¡£¡£Òò´Ë£¬£¬£¬CPCs×÷ΪÏÖÔÚ×îÓÐÏ£ÍûµÄÐÄÔàÌæ»»ÁÆ·¨¹©Ìåϸ°ûÖ®Ò»£¬£¬£¬Õ¹ÏÖ³öÁËÁÉÀ«µÄÁÙ´²Ó¦ÓÃÔ¶¾°¡£¡£¡£È»¶ø£¬£¬£¬CPCs½öÔÚÅßÌ¥·¢ÓýÀú³ÌÖб£´æ£¬£¬£¬ÔõÑù´Ó³ÉÄêÈË»ñÈ¡ºÍÀ©ÔöCPCsϸ°û³ÉΪؽ´ý½â¾öµÄÒªº¦ÎÊÌâ¡£¡£¡£
2022Äê3ÔÂ31ÈÕ£¬£¬£¬ngµç×ÓÓÎÏ·ÖÐɽҽѧԺ²Ü骽ÌÊÚÍŶÓÔÚÉúÎïҽѧ¹¤³ÌÁìÓòÖøÃûÆÚ¿¯Nature Biomedical EngineeringÆÚ¿¯£¨ÖпÆÔº1ÇøTOP£¬£¬£¬IF="23.7£©ÉϽÒÏþÁËÌâΪ¡°Reprogramming" of fibroblasts into expandable cardiovascular progenitor cells via small molecules in xeno-free conditions¡±µÄÂÛÎÄ¡£¡£¡£¸ÃÑо¿Ê×´ÎʹÓÃС·Ö×Ó»¯ºÏÎï×éºÏ½«Ð¡ÊóºÍÈ˳ÉÏËάϸ°ûÖرà³ÌΪCPCs£¨»¯Ñ§ÓÕµ¼µÄÐÄѪ¹Ü×æϸ°û£¬£¬£¬chemically induced CPCs, ciCPCs£©²¢ÊµÏÖÆä¹æÄ£»¯À©Ôö¡£¡£¡£½«ciCPCsÒÆÖ²ÖÁ¹£ËÀÐÄÔàºó£¬£¬£¬Æä¿ÉͬʱÔö½øñ£ºÛÇøÐļ¡ÖØÐÞºÍѪ¹Ü»¯£¬£¬£¬½ø¶øÏÔÖøÔö½ø¹£ËÀÐÄÔàÐÞ¸´ºÍÐĹ¦Ð§»Ö¸´¡£¡£¡£´Ó¶ø½¨ÉèÁË´Ó²¡ÈË×ÔÌåϸ°ûÖƱ¸ºÍÀ©ÔöCPCs£¬£¬£¬½ø¶øÓÃÓÚÐÄÔàÐÞ¸´µÄÐÂÕ½ÂÔ¡£¡£¡£
ͼע£ºÍ¨¹ýÌåϸ°ûÖرà³Ì»ñµÃµÄÐÄѪ¹Ü×æϸ°ûÖÎÁÆÐļ¡¹£ËÀ
ÖÐɽҽѧԺÌØƸ¸±Ñо¿Ô±Íõ¼Î²©Ê¿¼°¹Ëɺɺ²©Ê¿ÎªÂÛÎĵÄÅäºÏµÚÒ»×÷Õß¡£¡£¡£²Ü骽ÌÊÚΪÂÛÎĵÄͨѶ×÷Õß¡£¡£¡£¸ÃÑо¿Êܵ½¹ú¼ÒÖصãÑз¢ÍýÏë¡¢¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¡¢¼°¹ã¶«Ê¡¡°Öé½È˲ÅÍýÏ롱Òý½øÁ¢Òì´´ÒµÍŶӵÈÏîÄ¿µÄÖ§³Ö¡£¡£¡£
ÂÛÎÄÁ´½Ó£ºhttps://doi.org/10.1038/s41551-022-00865-7
µØµã:¹ãÖÝÊÐиÛÎ÷·135ºÅ Óʱà:510275
µç»°: 020-84112828
ngµç×ÓÓÎÏ·°æȨËùÓÐ COPYRIGHT?1999-2022 , SUN YAT-SEN UNIVERSITY